| 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
| 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |


2000

  1. Bissonnette R, Shapiro J, Zeng H, McLean DI, Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol. 2000 Nov;143(5):1032-5.
  2. Bolduc C, Shapiro J. DPCP for the treatment of alopecia areata. Skin Therapy Lett. 2000;5(5):3-4.
  3. Bolduc C, Shapiro J. Management of androgenetic alopecia. Am J Clin Dermatol. 2000 May-Jun;1(3):151-8.
  4. Carruthers J, Carruthers A, Zelichowska A. The Power of Combined Therapies - BOTOX and Ablative Facial Laser Resurfacing. Am J Cosmetic Surg 2000 17(3): 129-131.
  5. Carruthers A, Carruthers J. Toxins 99, new information about the botulinum neurotoxins. Dermatol Surg. 2000 Mar;26(3):174-6.
  6. Carruthers A, Chapter 24 – “Coblation for Facial Resurfacing” in Facial Rejuvenation, Edited by Paul Carniol, 2000 Wiley-Liss, Inc, p413-427. ISBN 0-471-31846-9.
  7. Cooper CL, Wiseman M, Brunham R. Bullous cellulitis caused by Serratia marcescens. Int J Infect Dis. 1998 Jul-Sep;3(1):36-8.
  8. Dutz J. Treatment options for localized scleroderma. Skin Therapy Letter 2000;5(2):3-5.
  9. Hobbs L, Sauder DN, Shapiro J, DeKoven J, Shear NH, Lui H. Open-Label Comparison of Plaque Psoriasis Treatment with Tazarotene 0.1% Gel Plus Mometasone Furoate 0.1% Cream Versus Mometason Furoate 0.1% Cream Alone. American Academy of Dermatology Annual Meeting, San Francisco, March 2000
  10. Hong C. My Inspirational Friend - Writing Award Honorable Mention. Dermatology Times of Canada July 2000.
  11. Kennedy C, Heacock HJ, Rivers JK. Chapter 2 - The Case Control Study. Cutaneous Biometrics. Edited by Doris A. Schwindt and Howard I. Maibach, Kluwer Academic/Plenum Publishers, New York. 2000:23-36.
  12. Kitson N, Thewalt JL. Hypothesis: the epidermal permeability barrier is a porous medium. Acta Derm Venereol Suppl (Stockh). 2000;208:12-5.
  13. Li G, Bush JA, Ho VC. Effect of retinoic acid on apoptosis and DNA repair in human keratinocytes after UVB irradiation. J Cutan Med Surg. 2000 Jan;4(1):2-7.
  14. Li G, Bush JA, Ho VC. p53-dependent apoptosis in melanoma cells after treatment with camptothecin. J Invest Dermatol. 2000 Mar;114(3):514-9.
  15. Lui H, Mamelak AJ. Psoriasis (Plaque). Emedicine.com from WebMD. April 2000. http://www.emedicine.com/derm/topic365.htm
  16. Lui H, Zeng H, MacAulay CE, Palcic B, McLean DI. US Patent: Fluorescence Scope System for Dermatologic Diagnosis. US Patent No. 6,021,344. February 1, 2000.
  17. Madani S, Huilgol SC, Carruthers A. Unplanned incomplete Mohs micrographic surgery. J Am Acad Dermatol. 2000 May;42(5 Pt 1):814-9.
  18. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000 Apr;42(4):549-66; quiz 567-70.
  19. Madani S, Trotter MJ, Shapiro J. Pseudopelade of Brocq in beard area. J Am Acad Dermatol. 2000 May;42(5 Pt 2):895-6.
  20. Maddin S. US FDA Advisory Committee Meetings Held to Discuss Isotretinoin, Safety Issues, and a New Accutane Formulation. Skin Therapy Letter 2000;6(2):5.
  21. Maddin S., Editor. Topical Antipsoriatics (1-2), Treatment Options for Localized Scleroderma (3-5). Skin Therapy Letter. 2000;5(2).
  22. Maddin S., Editor. Synopsis of Laser Assisted Hair Removal Systems (1-2,5), Drug Treatments For Skin Disease Introduced in 1999 (3-4). Skin Therapy Letter. 2000;5(3).
  23. Maddin S., Editor. Rising Drug Costs: The Impact on Dermatology (1-2,5), Herbal Anti-Inflammatory Agents for Skin Disease (3-5). Skin Therapy Letter. 2000;5(4).
  24. Maddin S., Editor. Systemic Drugs With Antipruritic Potency (1-2,5), DPCP for the Treatment of Alopecia Areata (3-4). Skin Therapy Letter. 2000;5(5).
  25. Maddin S., Editor. Vitiligo Management Update (1-2,5), Current Therapy in Behcet’s Disease (3-5). Skin Therapy Letter. 2000;5(6).
  26. Maddin S., Editor. Perspectives on Isotretinoin and the Canadian Consensus Guidelines on Treatment of Acne (1-4), US FDA Advisory Committee Meetings Held to Discuss Isotretinoin, Safety Issues and a New Accutane Formulation. (5) Skin Therapy Letter. 2000;6(2).
  27. McLean DI. Values, behavior, and medical practice: a personal view. Arch Dermatol. 2000 Jan;136(1):81-2.
  28. Rivers JK, Wiseman MC. Becker Melanosis. Emedicine.com from WebMD. March 2000. http://www.emedicine.com/derm/topic48.htm
  29. Rivers JK. Sunscreens: is an ounce of protection worth the hassle? Dermatol Surg. 2000 Jun;26(6):513-4.
  30. Sawaya ME, Shapiro J. Androgenetic alopecia: New, approved, and unapproved treatments. Dermatol Clin. 2000 Jan;18(1):47-61, viii.
  31. Shapiro J, Lui H. Chapter 7: Common Hair Loss Disorders. In: Atlas of Hair and Nails. Hordinsky M, Sawaya M. Scher R (Eds). Churchill Livingstone. 1999;91-103
  32. Shapiro J, Wiseman M, Lui H. Practical management of hair loss. Can Fam Physician. 2000 Jul;46:1469-77.
  33. Shoveller JA, Lovato CY, Peters P, Rivers JK. Canadian National Survey On Sun Exposure and Protective Behaviours - Outdoor Workers. Canadian J of Public Health. 2000;91(1):34-35.
  34. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes. 2000 Jan;49(1):1-7.
  35. Wiseman MC, Bolduc C, Shapiro J. A Review of Androgenetic Alopecia and its Management. Cosmetic Dermatology. June 2000.
  36. Wiseman MC. Words of Psoriasis. Dermatology Times of Canada Writing Award Winner 2000.
  37. Zeng H, Lui H, McAulay C, Palcic B, McLean DI. US Patent: Apparatus and Methods Relating to Optical Systems for Diagnosis of Skin Disease. US Patent No. 6,069,689, May 30, 2000
  38. Zhou Y, Barnett MJ, Rivers JK. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol. 2000 Jun;136(6):717-21.


« Back to Publications & Reports

05.19.09